RYARZIL
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Jan 2024)
What this means for you
This application is over — abandoned 08 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90188978
- Mark type
- Stylized text
- Filed
- 17 Sept 2020
- Published for opposition
- 12 Oct 2021
- Abandoned
- 08 Jan 2024
- Attorney of record
- John M. Mueller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for treatment of nerve agent exposure and acute radiation syndrome
Owner
- Eagle Pharmaceuticals Inc., Woodcliff Lake, NJ, US
- Eagle Pharmaceuticals Inc., Woodcliff Lake, NJ, US
Prosecution history
- 08 Jan 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Jan 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 07 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Jun 2023 — SOU EXTENSION 3 GRANTED
- 05 Jun 2023 — SOU EXTENSION 3 FILED
- 05 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 06 Jun 2023 — ASSIGNED TO EXAMINER
- 09 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Dec 2022 — SOU EXTENSION 2 GRANTED
- 07 Dec 2022 — SOU EXTENSION 2 FILED
- 07 Dec 2022 — SOU TEAS EXTENSION RECEIVED
- 08 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jun 2022 — SOU EXTENSION 1 GRANTED
- 06 Jun 2022 — SOU EXTENSION 1 FILED
- 06 Jun 2022 — SOU TEAS EXTENSION RECEIVED